Granules India appoints Ramraj Rangarajulu as President, Head of Formulations Operations

Written By :  Farhat Nasim
Published On 2024-10-17 12:47 GMT   |   Update On 2024-10-17 12:47 GMT
New Delhi: Granules India Limited has recently announced the appointment of Ramraj Rangarajulu as President and Head of Formulations Operations, effective October 14, 2024. Rangarajulu will be part of the company's Senior Management Personnel (SMP).

Anil Arora, the current President of Formulations Operations, will be superannuating in November 2024 and will be handing over all his responsibilities to Rangarajulu in the interim.

Ramraj is M. Pharm. from Dr. M.G.R. Medical University, Chennai and brings over 28 years of experience in the pharmaceutical industry, with expertise in formulation manufacturing, plant management, quality and regulatory affairs, operational excellence, productivity improvement, new product scale-up and launches, and customer service. He has worked with various dosage forms, including oral solid dosage (OSD), small volume parenterals, and topical formulations.

Advertisement
Prior to joining Granules India, Rangarajulu held leadership positions at Zydus Life Sciences, Aurobindo Pharma, Medreich, and Dr. Reddy's Laboratories. His most recent role was Senior Vice President & Cluster Head of Finished Dosage Manufacturing Operations at Zydus Life Sciences.
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News